Alivus Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 08, 2025
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences (formerly Glenmark Life Sciences) has issued the notice for its 14th AGM to be held on Monday, September 8, 2025 at 3:00 p.m. via video conferencing. The Board has recommended a final dividend of ₹5 per equity share (on a face value of ₹2) for FY2024-25, subject to shareholder approval. The record date and cut-off date for dividend eligibility and e-voting is September 1, 2025, with remote e-voting open from September 4 (9:00 a.m.) to September 7 (5:00 p.m.). Dividend, if approved, will be paid on or after September 12, 2025. Resolutions to be passed include adoption of audited FY25 financial statements, dividend declaration, and re-appointment of Mr. Vinod Naik (DIN: 03635487) as Executive Director, who retires by rotation. Two special business items seek shareholder approval to ratify the Cost Auditor's remuneration of ₹0.45 million for FY ending March 2026 and to appoint M/s. Bhadresh Shah & Associates as Secretarial Auditor for a five-year term covering FY2025-26 to FY2029-30.
Routine AGM notice with positive dividend confirmation of ₹5/share for income-focused shareholders. Shareholders holding shares as of September 1, 2025 will be eligible for the dividend and entitled to vote on the resolutions.